IHS Revises FY23 Sales Guidance To $2.08B-$2.11B From $2.19B-$2.22B Versus Consensus Of $2.09B; Sees Adjusted EBITDA Of $1.13B-$1.15B (Prior Guidance of $1.2B-$1.22B)
Portfolio Pulse from Benzinga Newsdesk
IHS has revised its FY23 sales guidance down to $2.08B-$2.11B from $2.19B-$2.22B, which is in line with the consensus of $2.09B. The company also lowered its adjusted EBITDA forecast to $1.13B-$1.15B from the previous guidance of $1.2B-$1.22B.
August 15, 2023 | 11:16 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IHS has lowered its FY23 sales and EBITDA guidance, which may negatively impact investor sentiment and potentially the stock price in the short term.
IHS has revised its FY23 sales guidance downwards, which is generally perceived negatively by the market as it indicates potential future revenue and profitability challenges. This could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100